← Product Code [CAF](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CAF) · K962872

# RESPIFLO (K962872)

_Tyco Healthcare Deutschaland GmbH · CAF · Feb 25, 1997 · Anesthesiology · SESD_

**Canonical URL:** https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CAF/K962872

## Device Facts

- **Applicant:** Tyco Healthcare Deutschaland GmbH
- **Product Code:** [CAF](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CAF.md)
- **Decision Date:** Feb 25, 1997
- **Decision:** SESD
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 868.5630
- **Device Class:** Class 2
- **Review Panel:** Anesthesiology
- **Attributes:** Therapeutic

## Indications for Use

For Inhalation and Humidification by way of Sterile Water in a closed system during Inhalation Therapy.

## Device Story

RESPIFLO is sterile, endotoxin-free water for inhalation therapy; packaged in disposable, closed-system containers. Used by clinicians in hospital or clinical settings to provide humidification during respiratory therapy. Device functions as a sterile fluid source for nebulizers or humidifiers; ensures patient safety by preventing contamination through closed-system design and single-use disposal. Benefits include reliable, sterile moisture delivery for respiratory support.

## Clinical Evidence

Bench testing only. Includes USP compliance for sterility and endotoxin levels, plus 3-year and 5-year stability testing.

## Technological Characteristics

Sterile, endotoxin-free water (USP compliant). Closed-system, disposable, single-use container. No electronic or software components.

## Regulatory Identification

A nebulizer is a device intended to spray liquids in aerosol form into gases that are delivered directly to the patient for breathing. Heated, ultrasonic, gas, venturi, and refillable nebulizers are included in this generic type of device.

## Predicate Devices

- Hudson RCI AQUAPAK

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

K962872

FEB 25 1997

510(K) SUMMARY

RESPIFLO

Applicant:
Kendall GmbH
Raffinieristrasse 18
93333
Neustadt an der Donau
Germany

Contact: Mr. Konrad Schmitt
Telephone: 09445/959/160
FAX: 09445/959/189

Submitted by:
Curtin & Associates International, Inc.
1200 East Street
Dedham, MA 02026

Contact: Mr. William D. Curtin
Telephone: 1.617.329.1955
FAX: 1.617.329.2529

Date this Summary was prepared: July 16, 1996

Trade Name: RESPIFLO
Common Name: Sterile Water for Inhalation Therapy

{1}

Legally Marketed Devices in Which Substantial Equivalence is claimed:

## Hudson RCI AQUAPAK

Description of the Device: This product is Sterile Water for Inhalation Therapy. It is packaged in a closed system and it is disposable after one use. The water is sterile and endotoxin free according to the USP. The product is used for Inhalation and Humidification during Inhalation Therapy.

Intended Use of the Device: For Inhalation and Humidification by way of Sterile Water in a closed system during Inhalation Therapy.

Summary of Technological Characteristics: This product is the exact same in nature and design as a currently marketed in the United States as the product used for Inhalation and Humidification during Inhalation Therapy.

Summary of Test Data:

- Sterile Water according to the USP
- Endotoxin free
- 3 year and 5 year Stability Testing
- Closed system and disposable, single use

See Test Data Results in Section 11, “Confidential Testing, Methods and Results.”

---

**Source:** [https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CAF/K962872](https://fda.innolitics.com/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CAF/K962872)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com